Correlation of Diaphragm Shear-Wave Elastography With Transdiaphragmatic Pressure in Healthy Adults: a Feasibility Study (PLEASSURE 1)

November 29, 2025 updated by: Wytze de Boer, Isala
Changes in intrapleural pressure after lung volume reduction in Chronic Obstructive Pulmonary disease (COPD) patients can lead to complications, including an increased risk of pneumothorax. This procedure, intended to improve lung function, may disturb the pressure balance within the pleural space, potentially precipitating pneumothorax. Careful monitoring of intrapleural pressure could help predict patients at risk. However, intrapleural pressure can currently only be measured invasively. Diaphragm shear-wave elastography (SWE) has been shown to reflect transdiaphragmatic pressure during isovolumetric inspiratory efforts and ventilation against inspiratory loading, and therefore may serve as a non-invasive surrogate for intrapleural pressure. This project outlines a stepwise study plan to evaluate SWE as a tool for intrapleural pressure monitoring (Figure 1). The project only moves to the next phase is the study previous phase was achieved successfully. The current protocol involves the first phase: to validate diaphragm SWE against transdiaphragmatic pressure and assess measurement reliability for local ultrasound systems in healthy adults.This prospective, single-centre, observational validation study will include twelve healthy adult volunteers. During a single study session, participants will perform standardized inspiratory efforts while simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (via esophageal and gastric balloon catheters), and mouth pressures are obtained. These methods are routinely applied in physiological research and carry minimal risk. Apart from brief nasal or throat discomfort during catheter placement, no significant adverse effects are expected. By establishing the relationship between diaphragm SWE, transdiaphragmatic pressure, and mouth pressures, this study aims to provide the essential validation step for future clinical research in COPD patients following lung volume reduction.

Study Overview

Detailed Description

Rationale:

Changes in intrapleural pressure after lung volume reduction in COPD patients may contribute to pneumothorax. Non-invasive monitoring of pleural pressure could help identify patients at risk. Diaphragm shear-wave elastography (SWE) has shown potential to reflect transdiaphragmatic pressure (Pdi), but has not yet been validated across ultrasound systems. This study aims to validate diaphragm SWE against gold-standard Pdi and mouth pressures in healthy volunteers before applying the technique in COPD patients.

Objective:

To validate diaphragm SWE as a non-invasive measure of inspiratory effort by assessing its correlation with transdiaphragmatic pressure (Pdi) and mouth pressure (PImax and submaximal inspiratory pressures). Secondary objectives are to determine feasibility and inter-rater reliability of SWE measurements.

Study design:

Prospective, single-centre, observational validation study.

Study population:

Twelve healthy adults aged 18-60 years, BMI 18-30 kg/m², without respiratory, neuromuscular or cardiothoracic disease.

Main study parameters/endpoints:

Participants will undergo simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (Pdi = Pga-Pes), and inspiratory mouth pressures (Pmo) at rest and during inspiratory efforts at 20%, 40%, and 60% of PImax. SWE will be performed twice by different operators to assess inter-rater reliability. The primary analysis will determine within-individual and overall correlations between SWE and Pdi.

- Pearson correlation coefficient repeated-measures correlation coefficient between SWE and Pdi across inspiratory efforts.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

The study involves a single measurement session (~1-2 hours). Procedures include nasal insertion of esophageal and gastric balloon catheters, mouth pressure measurements, and diaphragm ultrasound. These are routinely used physiological techniques with mild, transient, discomfort (e.g., mild throat or nasal irritation). No therapeutic intervention or follow-up is required. Risks are considered negligible and proportionate to the scientific value of the validation.

Study Type

Observational

Enrollment (Estimated)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Provincie Groningen
      • Groningen, Provincie Groningen, Netherlands, 9713GZ
        • University Medical Centre Groningen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy adults.

Description

Inclusion Criteria:

  • 18-60 years, BMI 18-30 kg/m²
  • No known respiratory, neuromuscular, or cardiothoracic disease
  • Able to perform inspiratory maneuvers and consent.

Exclusion Criteria:

  • Pregnancy
  • History of smoking (> 10 pack years)
  • Impaired swallowing, as well as esophageal diseases, or disorders at the level of the gastroesophageal sphincter

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
healthy adults
prospective validation cohort of healthy adults

Participants will undergo simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (Pdi = Pga-Pes), and inspiratory mouth pressures (Pmo) at rest and during inspiratory efforts at 20%, 40%, and 60% of PImax. SWE will be performed twice by different operators to assess inter-rater reliability. The primary analysis will determine within-individual and overall correlations between SWE and Pdi.

- Pearson correlation coefficient repeated-measures correlation coefficient between SWE and Pdi across inspiratory efforts.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
- Pearson correlation coefficient repeated-measures correlation coefficient between SWE and Pdi across inspiratory efforts.
Time Frame: 1 hour
Participants will undergo simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (Pdi = Pga-Pes), and inspiratory mouth pressures (Pmo) at rest and during inspiratory efforts at 20%, 40%, and 60% of PImax. SWE will be performed twice by different operators to assess inter-rater reliability. The primary analysis will determine within-individual and overall correlations between SWE and Pdi.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Estimated)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

November 29, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PLEASSURE 1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

small feasibility study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diaphragm Ultrasound

Clinical Trials on shear wave elastography of the diaphragm

Subscribe